Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=NEUTRAL -> MINT (human chose this in 93% of 255 past reviews)] Temporary healthcare access improvement outweighed by systemic risks of permanence and fiscal strain. | The Medicare obesity drug program is a positive step toward improving public health access and reducing obesity-related burdens, aligning with SDG 3. However, its temporary nature and potential to become permanent raise concerns about long-term sustainability and resource